| Item Type | Name |
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphoid
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid, Accelerated Phase
|
|
Concept
|
Leukemia, Myeloid
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Leukemia, Prolymphocytic, T-Cell
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Graft vs Leukemia Effect
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Academic Article
|
Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?
|
|
Academic Article
|
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
|
|
Academic Article
|
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
|
|
Academic Article
|
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Cardiac tamponade in a patient with chronic lymphocytic leukemia.
|
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
|
|
Academic Article
|
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
|
|
Academic Article
|
Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Pre-transplant serum ferritin is prognostic but is it useful?
|
|
Academic Article
|
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
|
|
Academic Article
|
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
|
|
Academic Article
|
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
|
|
Academic Article
|
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
|
|
Academic Article
|
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
|
|
Academic Article
|
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
|
|
Academic Article
|
Low-grade lymphoma.
|
|
Academic Article
|
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
|
|
Academic Article
|
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.
|
|
Academic Article
|
Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
|
|
Academic Article
|
Treatment of relapse after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.
|
|
Academic Article
|
Autologous bone marrow transplantation for leukemia and lymphoma.
|
|
Academic Article
|
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.
|
|
Academic Article
|
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
|
|
Academic Article
|
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications.
|
|
Academic Article
|
Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence.
|
|
Academic Article
|
Allogeneic and autologous transplantation for chronic lymphocytic leukemia.
|
|
Academic Article
|
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
|
|
Academic Article
|
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
|
|
Academic Article
|
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
|
|
Academic Article
|
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
|
|
Academic Article
|
Studies of decitabine with allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
|
|
Academic Article
|
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.
|
|
Academic Article
|
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy.
|
|
Academic Article
|
To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?
|
|
Academic Article
|
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
|
|
Academic Article
|
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
|
|
Academic Article
|
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
|
|
Academic Article
|
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for low-grade lymphoma.
|
|
Academic Article
|
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
|
|
Academic Article
|
High-dose melphalan allows durable engraftment of allogeneic bone marrow.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
|
|
Academic Article
|
Reduced-intensity and nonmyeloablative conditioning regimens.
|
|
Academic Article
|
Peripheral-blood versus bone marrow stem cells.
|
|
Academic Article
|
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?
|
|
Academic Article
|
Invasive Aspergillus sinusitis during bone marrow transplantation.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
Cord blood chimerism and relapse after haplo-cord transplantation.
|
|
Academic Article
|
Clofarabine as a bridge to hematopoietic stem cell transplant.
|
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
|
|
Academic Article
|
Preleukemic state preceding adult acute lymphoblastic leukemia.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
|
|
Academic Article
|
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
|
|
Academic Article
|
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
|
|
Academic Article
|
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation.
|
|
Academic Article
|
Donor graft genotypes versus leukemia.
|
|
Academic Article
|
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
|
|
Academic Article
|
Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?
|
|
Academic Article
|
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?
|
|
Academic Article
|
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
|
|
Academic Article
|
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations.
|
|
Academic Article
|
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
|
|
Grant
|
Busulfan conditioning: optimization, kinetics, genomics
|
|
Grant
|
Minor Histocompatilibity Vaccination After Allo-Transpl*
|
|
Academic Article
|
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
|
|
Academic Article
|
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
|